News and Press Releases

NIH and Exothera collaborate to produce GMP intranasal vaccine against SARS-CoV-2 for clinical phase I/II trial in Africa and US

16 August 2023 -- Maryland, US and Jumet, Belgium -- The National Institutes of Health (NIH), the US’s medical research agency, selected Exothera, a full-service Contract Development and Manufacturing Organisation...

Category: Other
Posted: August 23, 2023

Zoning de Jumet, Allée Centrale 52, 6040 Jumet - BELGIUM

MODERNA CLINICAL TRIAL DATA CONFIRMS ITS UPDATED COVID-19 VACCINE GENERATES ROBUST IMMUNE RESPONSE IN HUMANS AGAINST WIDELY CIRCULATING VARIANTS 

Updated COVID-19 vaccine effectively targets EG.5, a dominant variant of concern, as well as the rapidly spreading FL 1.5.1 variant  Updated vaccine expected to be available, pending approval, in coming weeks...

Category: Other
Posted: August 22, 2023

Global Headquarters 200 Technology Square Cambridge, MA 02139